Merged into Immunovant, ticker now IMVT
HSAC

Completed

Immunovant

IMVT
First $9.80
Merger $15.97
63%
Merger +6mo $23.39
139%
Merger +1yr $43.30
342%
Recent $14.87
52%

Health Sciences Acquisitions Corporation

Underwriter: Chardan, UBS Secruities
Raised
$100M
CIK
1764013
SPAC Ticker
HSACU
Merger
Immunovant
Merged Ticker
IMVT
Focus
Biopharma & medical technology in North America or Europe
External link: SEC Filings